Skip to main content
Clinical Trials/NCT06458049
NCT06458049
Active, not recruiting
Not Applicable

Sexual Health and Rehabilitation Online (SHAREonline): An Educational Intervention for Young Adult Women After Cancer

Dana-Farber Cancer Institute1 site in 1 country84 target enrollmentFebruary 19, 2025

Overview

Phase
Not Applicable
Intervention
Group Session
Conditions
Cancer Survivorship
Sponsor
Dana-Farber Cancer Institute
Enrollment
84
Locations
1
Primary Endpoint
Change in Sexual Function
Status
Active, not recruiting
Last Updated
2 months ago

Overview

Brief Summary

SHAREonline is a study for young female cancer survivors that are experiencing changes in sexual health and function.

The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual health and functioning.

Detailed Description

The purpose of this research is to compare two brief interventions delivered by videoconference to learn if they help women effectively manage these changes and restore sexual health and functioning. Participants in this study would first complete health questionnaires and then be randomized to take part in one of two types of education sessions delivered by an instructor over videoconference: 1) Group education session or 2) Individual self-management session. About 56 women will receive the group education session and about 28 will receive the individual self-management session. It is expected that about 84 women will take part in this study.

Registry
clinicaltrials.gov
Start Date
February 19, 2025
End Date
May 31, 2027
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sharon Bober, Ph.D

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Female cancer survivors age 19-49
  • Cancer diagnosis (except non-melanoma skin cancer) ≥ 1 year prior
  • Diagnosed with first cancer ≥ age 18
  • No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned
  • Ability to read and write in English
  • Bothered by significant sexual dysfunction as evidenced by a Female Sexual Functioning Index (FSFI) score of ≤
  • Regular access to the internet

Exclusion Criteria

  • Has never been sexually active
  • Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently

Arms & Interventions

SHAREonline

Participants will receive: * One online group session structured around three 60-minute modules and creation of a personal action plan * Single Coaching phone call at one month * Questionnaires to complete at baseline, 2 and 4 Months

Intervention: Group Session

SHAREonline

Participants will receive: * One online group session structured around three 60-minute modules and creation of a personal action plan * Single Coaching phone call at one month * Questionnaires to complete at baseline, 2 and 4 Months

Intervention: Coaching Call

Individual Self Management

Brief individualized session with online and written materials and guidance. All Participants will complete study questionnaires at baseline, 2 months and 4 months post intervention

Intervention: Educational Materials

Outcomes

Primary Outcomes

Change in Sexual Function

Time Frame: Baseline to 2 months

The Female Sexual Function Index (FSFI Full Scale Score), is 19-item instrument which measures sexual function, including desire, orgasm, pain and satisfaction.

Secondary Outcomes

  • Study Engagement Rate(Baseline to 1 month)
  • Intervention Completion Rate(Baseline to 4 months)
  • Enrollment Rate(Baseline to 1 month)
  • Change in Emotional Distress(Baseline to 4 months)
  • Change in Sexual Function(Baseline to 4 months)
  • Intervention Acceptability Rate(Up to 1 month-post intervention)
  • Distress about Sexual Function(Baseline to 4 months)
  • Sexual Function, Satisfaction and Sexual Inactivity(Baseline to 2 months)
  • Distress about Sexual Function(Baseline to 2 months)
  • Change in Emotional Distress(Baseline to 2 month)

Study Sites (1)

Loading locations...

Similar Trials